gene
discov
follow
isol
first
character
protein
chemokin
structur
relat
group
accord
rel
posit
conserv
cystein
residu
along
respect
receptor
belong
chemokin
subfamili
whose
chemokin
present
adjac
cystein
compris
major
chemokin
facilit
read
chemokin
refer
shown
induc
vitro
migrat
recruit
cell
dendrit
cell
eosinophil
nk
cell
mast
cell
basophil
although
initi
consid
cellspecif
cytokin
henc
origin
name
rant
produc
platelet
macrophag
eosinophil
fibroblast
endothelium
epitheli
endometri
cell
varieti
cell
express
mediat
effect
implic
chemokin
multipl
biolog
process
pathogen
control
enhanc
inflamm
sever
steril
disord
cancer
atherosclerosi
current
tool
avail
studi
list
tabl
mani
biolog
effect
chemokin
mediat
interact
chemokin
receptor
cell
surfac
relev
known
receptor
figur
depict
interact
receptor
also
known
chemokin
ligand
bind
affin
bind
receptor
variabl
greater
affin
bind
less
affin
process
cell
recruit
vivo
oligom
immobil
endotheli
glycosaminoglycan
gag
interact
receptor
express
incom
leukocyt
blood
vessel
oligomer
essenti
activ
vitro
demonstr
crucial
vivo
activ
well
gag
bind
heterodimer
enhanc
biolog
function
exampl
may
amplifi
monocyt
arrest
endothelium
turn
chemokin
receptor
fulli
function
monom
also
form
homo
heterodim
allow
new
properti
receptor
cointern
crossdesensit
differenti
signal
figur
oligom
interact
receptor
three
extracellular
loop
aminotermin
portion
format
complex
caus
conform
chang
receptor
activ
subunit
gprotein
lead
increas
level
cyclic
amp
inositol
triphosph
intracellular
calcium
signal
event
caus
cell
polar
transloc
result
increas
phagocyt
abil
cell
surviv
transcript
proinflammatori
gene
mani
chemokin
chemokin
receptor
also
abl
induc
g
proteinindepend
signal
g
proteindepend
signal
occur
complex
intern
via
chlatrinmedi
endocytosi
associ
adapt
molecul
cytoplasm
organel
vacuol
recruit
perform
recycl
receptor
andor
degrad
activ
complex
effect
import
regul
receptor
level
extern
membran
allow
regul
cellular
activ
reduct
extracellular
level
chemokin
import
maintain
homeostasi
chemokin
system
also
featur
group
atyp
receptor
bind
trigger
usual
signal
event
interact
due
uncoupl
signal
machineri
unlik
chemokin
receptor
main
role
decoy
receptor
appear
sequest
ligand
therefor
function
chemokin
scaveng
best
known
exampl
decoyreceptor
bind
darc
figur
follow
topic
experiment
studi
investig
role
variou
diseas
describ
product
observ
viral
infect
respiratori
tract
includ
infect
hantaviru
reoviru
adenoviru
coxsacki
viru
rhinoviru
respiratori
syncyti
viru
rsv
wellknown
coronaviru
influenza
viru
unifi
featur
pathogen
respiratori
tract
virus
mani
possess
rna
genom
studi
point
doublestrand
rna
intermedi
form
viral
genom
replic
activ
contribut
eosinophil
inflamm
airway
mediat
may
aggrav
chronic
diseas
asthma
exampl
shown
hantavirus
may
caus
lifethreaten
hemorrhag
cardiopulmonari
syndrom
induc
vitro
sever
cell
type
infect
patient
earli
express
commonli
trigger
nonpathogen
hantavirus
prospect
hill
viru
pathogen
virus
evad
immun
detect
delay
product
case
hantaan
viru
believ
play
role
initi
control
viral
replic
would
prevent
prolong
proinflammatori
respons
like
contribut
diseas
pathogenesi
rsv
common
etiolog
agent
lower
respiratori
tract
infect
infant
induc
obstruct
lung
diseas
bronchial
asthma
children
rsv
infect
increas
level
airway
secret
express
upper
airway
correl
posit
diseas
sever
use
murin
model
rsv
infect
culley
et
al
found
express
occur
two
phase
first
consequ
innat
respons
resid
lung
cell
second
deriv
cell
treatment
metrant
function
inhibitor
second
phase
product
reduc
immunopatholog
suggest
receptor
play
central
role
drive
inflamm
rsv
lung
diseas
howev
chemokin
blockad
first
phase
show
opposit
effect
make
difficult
anticip
would
effect
target
pathway
clinic
studi
sever
acut
respiratori
syndrom
sar
acut
lifethreaten
respiratori
ill
differ
sever
coronaviru
infect
elev
serum
level
chemokin
sar
patient
suggest
sar
pathogenesi
may
due
immun
dysregul
law
et
al
found
protein
sar
coronaviru
strong
induc
human
lung
epitheli
cell
contrast
protein
nonpathogen
coronavirus
anoth
studi
acut
respiratori
infect
combin
treatment
antivir
blockad
result
increas
surviv
pneumovirusinfect
mice
find
corrobor
idea
sar
pathogenesi
similar
respiratori
syndrom
strong
immuneinflammatori
compon
target
intervent
final
shown
involv
influenza
viru
infect
vitro
infect
human
alveolar
macrophag
strain
show
increas
mrna
express
also
studi
demonstr
elev
lung
patient
interestingli
compar
analysi
season
influenza
strain
pandem
strain
reveal
pandem
strain
induc
greater
level
human
macrophag
relat
abil
pandem
strain
suppress
rigi
express
result
elev
chemokin
level
could
contribut
cytokin
storm
present
sever
flu
patient
evalu
role
influenza
paramyxoviru
infect
tyner
et
al
infect
mice
demonstr
axi
provid
antiapoptot
signal
virusinfect
macrophag
usual
apoptosi
infect
cell
would
help
host
enhanc
apoptosi
infect
macrophag
depriv
signal
reduc
clearanc
virus
infect
cell
debri
contribut
tissu
damag
thu
activ
import
extend
macrophag
surviv
control
infect
neuroinflamm
inflamm
central
nervou
system
cn
must
care
regul
avoid
immunemedi
neuron
death
induc
sever
model
viral
cn
infect
particip
activ
microglia
recruit
lymphocyt
nk
cell
could
either
result
pathogenesi
viral
clearanc
astrocyt
abl
secret
expos
dsrna
analogu
poli
c
expos
prr
ligand
product
astrocyt
shown
contribut
pathogenesi
infect
borna
diseas
viru
caus
neuron
death
directli
fact
neuron
degener
mediat
microglia
activ
astrocytederiv
murin
model
lymphocyt
choriomening
viru
known
cell
mediat
pathogenesi
cn
investig
lin
et
al
demonstr
induc
product
proinflammatori
chemokin
microgliamacrophag
enhanc
neuroinflamm
culmin
mice
weight
loss
rabi
viru
rv
induc
product
microglia
replic
activ
induct
control
protein
n
rv
pathogen
strain
prevent
rigi
activ
product
lead
diseas
lethal
infect
mice
contrast
zhao
et
al
infect
mice
genet
modifi
rv
strain
overexpress
purpos
vaccin
found
strain
caus
extens
neuroinflamm
culmin
neurolog
diseas
mice
death
thu
confirm
major
role
play
leukocyt
recruit
cn
besid
deleteri
proinflammatori
role
could
play
cn
chemokin
protect
rv
virus
wellstudi
exampl
involv
acut
infect
west
nile
viru
wnv
mice
lack
lead
decreas
leukocyt
recruit
increas
viral
load
cn
enhanc
mortal
wnv
infect
induc
high
continu
level
requir
local
accumul
nk
cell
macrophag
lymphocyt
control
infect
agreement
find
epidemiolog
studi
found
human
possess
allel
prone
symptomat
infect
wnv
due
defect
similar
observ
made
tickborn
enceph
viru
indic
cell
recruit
could
common
mechan
resist
neurotrop
flavivirus
among
herp
virus
herp
simplex
virus
neurotrop
virus
caus
enceph
newborn
immunocompromis
human
shown
produc
herpet
enceph
mice
mediat
cell
recruit
cn
report
demonstr
upregul
latent
infect
trigemin
ganglia
major
featur
infect
result
retent
lymphocyt
neuron
mice
human
prevent
viral
reactiv
larg
dna
virus
herp
virus
present
high
level
adapt
human
host
known
caus
latent
infect
immun
suppress
condit
herp
virus
may
reactiv
caus
neurolog
diseas
latenc
possibl
due
abil
viru
evad
immun
surveil
commonli
block
effect
proinflammatori
chemokin
human
herp
viru
hhv
block
strategi
chemokin
mani
includ
viral
chemokin
antagon
viral
chemokinebind
protein
bind
chemokin
nanomolar
affin
gpcr
induc
cell
prolifer
human
cytomegaloviru
hcmv
particularli
dedic
control
biolog
function
encod
microrna
downregul
express
chemokinebind
protein
bind
picomolar
rate
prevent
interact
host
chemokin
receptor
indic
import
mediat
control
hcmv
infect
infecti
liver
diseas
major
threat
human
health
hepat
c
viru
hcv
infect
caus
chronic
hepat
inflamm
risk
develop
cirrhosi
hepatocellular
carcinoma
polymorph
gene
show
protect
hepat
c
sinc
mutat
posit
increas
express
result
reduc
portal
inflamm
milder
fibrosi
convers
patient
carri
allel
also
reduc
inflamm
fibrosi
indic
pathway
could
play
role
diseas
pathogenesi
anoth
studi
hepat
b
viru
hbv
found
similar
result
combin
polymorph
associ
recoveri
hbv
infect
yellow
fever
viru
yfv
caus
agent
hemorrhag
fever
characterist
clinic
present
due
sever
liver
injuri
henc
name
yellow
fever
yfv
infect
success
control
vaccin
attenu
live
strain
though
small
percentag
vaccine
develop
yellow
fever
studi
pulendran
et
al
describ
uniqu
yfv
vaccineassoci
viscerotrop
diseas
patient
present
persist
viremia
robust
activ
b
lymphocyt
increas
number
circul
monocyt
observ
associ
genet
background
patient
heterozyg
gene
variant
lead
aberr
immun
respons
yfv
vaccin
dengu
viru
denv
close
relat
yfv
caus
similar
hemorrhag
fever
emerg
major
world
health
problem
past
decad
recent
find
dengu
confirm
denv
infect
damag
liver
due
elev
serum
transaminas
level
sever
diseas
patient
histolog
analysi
liver
section
dengu
fatal
case
show
lymphocyt
kupfer
cell
sinusoid
endothelium
posit
stain
correl
increas
hepat
level
observ
acut
dengu
patient
increas
hepat
due
denv
infect
could
mediat
leukocyt
recruit
organ
contribut
system
inflamm
culmin
hemorrhag
phenomena
product
also
describ
dengu
model
mice
level
concomit
liver
injuri
howev
known
contribut
injuri
produc
consequ
tissu
damag
dengu
conclus
context
respiratori
neurotrop
viral
infect
seem
product
present
dual
role
necessari
control
certain
viral
infect
includ
influenza
rsv
rv
hsv
wnv
antivir
role
evid
hcmv
infect
immun
evas
mechan
target
essenti
activ
employ
virus
howev
seem
deleteri
later
phase
infect
contribut
excess
inflamm
tissu
damag
diseas
address
section
thu
conceptu
would
ideal
block
later
phase
infect
immunopatholog
main
compon
respiratori
neurotrop
diseas
rather
viru
role
liver
infect
clear
especi
benefici
detriment
effect
depend
chemokin
receptor
engag
whether
infect
chronic
viral
hepat
acut
yfv
denv
howev
inflamm
common
featur
infect
later
phase
contribut
fibrosi
hemorrhag
manifest
depend
infect
therefor
potenti
blockad
receptor
context
viral
infect
could
employ
later
stage
diseas
order
prevent
immunopatholog
earlier
treatment
could
deleteri
effect
capac
host
deal
viral
infect
separ
earli
viralmedi
late
immunemedi
phase
diseas
viral
infect
may
problemat
clinic
context
like
strategi
aim
block
receptor
may
use
patient
clear
except
hiv
case
blockad
associ
decreas
viral
entri
block
context
hiv
unlik
achiev
similar
benefit
infect
mansoni
may
evolv
chronic
ill
fibrot
liver
injuri
character
format
granuloma
around
parasit
egg
studi
souza
et
al
liver
granuloma
chronic
infect
mice
show
cell
greater
collagen
deposit
comparison
wt
mice
associ
higher
level
therefor
abrog
deleteri
experiment
mansoni
infect
due
enhanc
fibrosi
granulomat
inflamm
among
differ
consequ
mansoni
infect
periport
fibrosi
liver
seriou
event
involv
remodel
extracellular
matrix
excess
deposit
collagen
primarili
hepat
stellat
cell
booth
et
al
demonstr
high
concentr
adult
men
singl
risk
factor
mansoniinduc
node
size
low
level
protect
patient
also
express
low
level
comprehens
analysi
chemokin
express
mous
model
mansoni
infect
show
level
higher
respons
enhanc
exampl
administr
combin
egg
antigen
studi
accord
report
state
protect
mansoni
infect
suggest
high
level
result
reduc
granuloma
addit
chensu
et
al
studi
pulmonari
granuloma
elicit
antigen
mansoni
show
play
differ
role
granuloma
format
specif
contribut
inflamm
limit
respons
analog
effect
polar
immun
respons
find
suggest
import
regulatori
molecul
play
distinct
role
inflammatori
respons
schistosomiasi
howev
differ
context
genet
ablat
shown
effici
bind
promot
nk
cell
recruit
activ
cell
mediat
hepat
model
thu
increas
bind
upon
blockad
delet
would
addit
aspect
explain
discrep
neutral
strategi
differ
diseas
context
aspect
therefor
taken
account
design
therapeut
strategi
assign
specif
role
overal
appear
infect
mice
patient
schistosomiasi
present
mild
form
diseas
develop
adapt
immun
respons
greater
activ
convers
sever
form
diseas
associ
increas
activ
activ
would
predominantli
mediat
activ
would
predominantli
mediat
despit
share
nearli
ident
receptor
affin
specif
well
defin
result
oppos
activ
regard
clinic
present
diseas
evid
protect
schistosomiasi
immun
respons
develop
helminth
pathogen
contribut
gener
mainten
granuloma
thu
potenti
pharmacolog
drug
develop
priorit
activ
order
prevent
immunopatholog
administr
patient
like
caus
unwant
effect
blockad
addit
antischistosom
drug
could
potenti
valu
patient
sever
diseas
allerg
inflammatori
diseas
usual
develop
tissu
present
larg
epitheli
surfac
area
lung
skin
gut
understand
tissuespecif
memori
inflammationspecif
cell
traffick
facilit
develop
allerg
diseas
would
great
therapeut
interest
anim
model
acut
allerg
inflamm
cytokin
chemokin
shown
induc
eosinophil
airway
inflamm
antigenspecif
ige
product
airway
hyperrespons
identifi
airway
asthmat
patient
induc
eosinophil
recruit
receptor
airway
inflamm
cytokineschemokin
product
import
marker
asthma
asthmat
respons
complex
difficult
transpos
experiment
model
mediat
eosinophil
neutrophil
monocyt
recruit
airway
initi
import
event
inflammatori
respons
integrin
activ
lipid
mediat
biosynthesi
degranul
constitut
express
lung
bronchoalveolar
fluid
patient
asthma
sever
vivo
studi
describ
recruit
eosinophil
allerg
airway
inflamm
treatment
metrant
decreas
eosinophilia
antigen
challeng
regard
contribut
develop
airway
hyperrespons
ahr
koya
et
al
report
repeat
allergen
challeng
sensit
mice
upregul
diseas
reduc
similar
schistosomiasi
ahr
shown
modul
cytokin
product
induc
shift
mechan
exploit
kline
et
al
administr
cpg
allergen
reduc
ahr
airway
eosinophilia
due
increas
express
suppress
eotaxin
product
deleteri
influenc
rsv
infect
airway
allergi
confirm
john
colleagu
link
product
exacerb
ahr
rsv
infect
per
se
adopt
transfer
cell
rsvinfect
mice
allergensensit
mice
induc
ahr
sensit
mice
suggest
lymphocyt
could
sourc
context
observ
support
previou
report
releas
cytotox
lymphocyt
viral
infect
bring
mitig
evid
rsv
infect
releas
chemokin
ie
may
play
signific
role
enhanc
lung
inflamm
allerg
challeng
asthma
complex
condit
much
evid
suggest
express
patient
diseas
correl
diseas
sever
moreov
preclin
studi
suggest
receptor
may
contribut
diseas
pathogenesi
certain
virus
rsv
may
worsen
experiment
allerg
airway
inflamm
blockad
may
also
prevent
exacerb
condit
therefor
target
context
human
asthma
could
potenti
therapeut
interest
nevertheless
report
suggest
may
drive
immunoregulatori
mechan
decreas
airway
hyperreact
role
atherosclerosi
extens
address
sever
studi
past
year
express
detect
atherosclerot
plaqu
monocytemacrophag
regul
rel
protein
moreov
kruppellik
factor
origin
design
rant
factor
late
activ
recent
identifi
new
transcript
factor
regul
express
cell
smooth
muscl
cell
smc
express
control
transcript
regul
ybox
bind
shown
overexpress
arteri
smc
greatli
increas
transcript
activ
eventu
lead
monocyt
recruit
express
cell
type
particip
atherosclerosi
ie
monocytesmacrophag
lymphocyt
mediat
arrest
transendotheli
diapedesi
result
full
transmigr
inflam
tissu
receptor
also
implic
detriment
effect
caus
emigr
cell
atherosclerot
lesion
site
blockad
receptor
distinct
role
atherosclerosi
genet
ablat
reduc
extent
atherosclerot
lesion
induc
diet
late
respons
lead
stabl
plaqu
reduc
mononuclear
infiltr
induc
immun
respons
contrast
lack
enhanc
atherosclerot
plaqu
develop
exacerb
local
accumul
cell
model
arteri
wire
injuri
mice
defici
protect
neointima
format
attribut
upregul
neointim
smc
model
defici
affect
neointim
area
cell
accumul
led
increas
separ
knockdown
reduc
express
carotid
arteri
led
signific
reduct
neointima
format
macrophag
accumul
injuri
protect
induc
knockdown
observ
treatment
metrant
indic
effect
depend
activ
express
within
atherosclerot
plaqu
platelet
also
repres
import
sourc
patholog
nonpatholog
vascular
condit
mice
platelet
shown
exacerb
atherogenesi
deposit
heterodim
trigger
monocyt
arrest
inflam
endothelium
treatment
specif
inhibitor
interact
attenu
monocyt
recruit
reduc
atherosclerosi
without
compromis
aspect
immun
respons
accord
cur
treatment
rant
disrupt
interact
gag
limit
atherosclerot
plaqu
format
increas
plaqu
stabil
mice
indic
protect
effect
blockad
atherosclerosi
akin
asthma
good
evid
express
may
play
role
human
atherosclerosi
experiment
studi
mostli
focus
receptor
role
drive
diseas
straight
forward
may
opposit
studi
target
modifi
protein
eg
rant
suggest
play
deleteri
role
experiment
atherosclerosi
whether
translat
clinic
benefit
human
known
present
associ
chronic
inflamm
may
play
direct
role
angiogenesi
angiogenesisdepend
process
progress
tumor
latter
effect
could
due
leukocyt
nonleukocyt
recruit
activ
angiogenesi
character
sprout
new
vessel
preexist
activ
endotheli
cell
migrat
prolifer
form
new
vessel
event
help
form
anastom
connect
newli
form
vessel
final
split
arteriol
capillari
homeostasi
angiogenesi
particip
embryogenesi
organ
develop
well
tissu
remodel
patholog
condit
chemokin
shown
contribut
angiogenesi
balanc
stimul
inhibit
endotheli
cell
prolifer
branch
main
chemokin
studi
angiogenesi
cxc
chemokin
cc
chemokin
also
describ
contribut
process
involv
context
inflammatori
angiogenesi
previous
shown
exampl
model
spongeinduc
inflammatori
angiogenesi
antiangiogen
activ
express
detect
earli
spong
implant
level
significantli
increas
thereaft
exogen
administr
reduc
angiogenesi
wt
mice
via
effect
mice
accord
observ
treatment
wt
mice
metrant
prevent
neutrophil
macrophag
accumul
enhanc
spong
vascular
contrast
sever
studi
suggest
may
consid
proangiogen
factor
oligomer
bind
gag
essenti
induc
angiogen
effect
inde
mice
reduc
corneal
neovascular
correl
reduc
express
vegf
suggest
key
player
process
corneal
neovascular
thu
could
associ
vegf
context
angiogenesi
support
vitro
studi
show
promot
endotheli
cell
migrat
spread
neovessel
format
moreov
metrant
reduc
endotheli
progenitor
cell
home
activ
glomerular
endothelium
vitro
vivo
rat
model
glomerulonephr
tumor
known
recruit
blood
vessel
continu
growth
promot
potenti
rout
metastasi
express
varieti
cancer
metastat
process
breast
carcinoma
melanoma
papillari
thyroid
carcinoma
instanc
chemokin
express
malign
stromal
cell
contribut
extent
phenotyp
tumorassoci
leukocyt
angiogenesi
gener
fibroblast
stroma
fact
recruit
monocyt
macrophag
precursor
tumor
microenviron
posit
correl
extent
myeloid
cell
infiltr
tumor
progress
tumor
express
low
level
exhibit
decreas
growth
rate
vivo
associ
greater
tumorspecif
cell
respons
convers
tumor
express
high
level
induc
reduc
cell
respons
upregul
matrix
transcript
contribut
angiogenesi
observ
indic
tumorderiv
facilit
tumor
growth
inhibit
cell
respons
enhanc
angiogenesi
chemokin
may
also
provid
surviv
signal
malign
cell
sinc
cell
gain
function
chemokin
receptor
may
contribut
metastat
activ
malign
cell
acquir
leukocytelik
properti
abl
respond
chemokin
gradient
site
metastasi
secret
senesc
age
fibroblast
induc
prolifer
prostat
epitheli
cell
induc
express
gene
relat
angiogenesi
interact
cancer
local
microenviron
determin
properti
growth
metastasi
osteopontin
promot
stromal
cell
msc
mediat
breast
cancer
metastasi
increas
msc
migrat
metastat
site
lung
liver
promot
tumor
progress
via
transform
msc
cancerassoci
fibroblast
collect
data
suggest
play
central
role
cancer
progress
affect
tumor
directli
control
leukocyt
recruit
angiogenesi
thu
therapi
block
receptor
could
potenti
help
treatment
cancer
metastasi
given
blockad
reduc
tumor
angiogenesi
opposit
fibrosi
commonli
result
chronic
inflamm
fibrosi
defin
excess
collagen
accumul
around
inflam
damag
tissu
lead
perman
scar
organ
malfunct
ultim
death
relat
major
patholog
featur
differ
chronic
autoimmun
diseas
fact
fibrogen
diseas
associ
express
activ
patient
local
scleroderma
signific
increas
mrna
found
lesion
local
cytoplasm
alveolar
macrophag
sarcoidosi
alveolar
macrophag
eosinophil
fibros
alveol
also
express
associ
increas
number
lymphocyt
bronchoalveolar
lavag
indic
may
mediat
tlymphocyt
influx
collect
import
fibrosi
diffus
lung
diseas
cell
sourc
alveolar
macrophag
macrophag
eosinophil
separ
mous
model
lung
fibrosi
induc
bleomycin
axi
axi
associ
presenc
intrapulmonari
fibrocyt
collagen
accumul
also
link
high
number
macrophag
myofibroblast
antagonist
metrant
use
evalu
role
hepat
fibrosi
induc
carbon
tetrachlorid
metrant
block
effect
hematopoiet
cellsderiv
cultur
stellat
cell
inhibit
migrat
prolifer
chemokin
secret
collagen
deposit
importantli
vivo
administr
metrant
amelior
liver
fibrosi
mice
abl
acceler
fibrosi
regress
suggest
blockad
reduc
inflamm
may
use
treat
liver
fibrosi
metrant
also
diminish
earli
infiltr
activ
mononuclear
cell
kidney
fibrosi
chronic
allograft
nephropathi
import
reduct
express
pdgfb
sole
blockad
instead
blockad
caus
metrant
treatment
also
employ
prevent
chronic
inflamm
tissu
remodel
mice
resist
myocardi
infarct
present
reduc
recruit
proinflammatori
cell
earli
infarct
associ
increas
tissu
heal
also
implic
organ
transplant
reject
would
mediat
recruit
mononuclear
cell
destroy
transplant
tissu
contribut
transplant
dysfunct
loss
treatment
smallmolecul
antagonist
prolong
allograft
reject
heart
transplant
model
rat
improv
heart
transplant
surviv
attribut
reduc
endotheli
damag
blockad
reduc
monocyt
arrest
transplant
heart
endothelium
anoth
studi
bx
reduc
progress
chronic
renal
allograft
damag
also
reduct
mononuclear
cell
recruit
renal
tissu
decreas
number
mononuclear
cell
led
reduct
collagen
deposit
level
interstiti
myofibroblast
accumul
renal
allograft
data
suggest
blockad
receptor
may
repres
therapeut
opportun
fibrosi
transplant
reject
sinc
blockad
effect
reduc
leukocyt
recruit
prevent
tissu
damag
remodel
whether
blockad
would
achiev
similar
result
need
determin
mani
epidemiolog
clinic
studi
sever
human
diseas
demonstr
express
correl
indic
diseas
activ
data
compound
mani
preclin
studi
show
function
role
receptor
overal
good
evid
uniqu
role
drive
recruit
leukocyt
angiogenesi
fibrosi
variou
model
chronic
inflamm
therefor
blockad
receptor
may
use
decreas
inflammatori
cell
influx
fibrosi
chronic
diseas
possibl
target
drug
includ
chronic
lung
diseas
asthma
pulmonari
fibrosi
liver
fibrosi
atherosclerosi
also
good
evid
may
play
role
drive
angiogenesi
tumor
growth
suggest
therapi
may
use
adjunct
therapi
certain
solid
tumor
moreov
good
data
suggest
play
relev
role
immun
respons
certain
infect
especi
viral
infect
notion
chemokin
system
redund
promiscu
clearli
distinct
role
play
chemokin
receptor
could
eventu
translat
novel
therapi
genet
function
defici
blockad
antagonist
clearli
benefici
context
hiv
infect
role
receptor
context
viral
diseas
much
less
clear
wherea
may
hostprotect
effect
earli
phase
viral
infect
may
also
contribut
diseas
pathogenesi
drive
influx
cell
may
damag
tissu
dual
effect
make
difficult
target
chemokin
human
diseas
difficult
make
clear
distinct
phase
viral
replic
immunopatholog
may
argu
target
could
ad
avail
antivir
drug
inde
possibl
drug
develop
face
issu
time
recognit
etiolog
viral
infect
clinic
set
particularli
interest
role
play
diseas
caus
flavivirus
virus
compos
flaviviru
genr
infect
pathogen
caus
intens
inflammatori
respons
may
manifest
enceph
hemorrhag
fever
depend
viral
tropism
compon
intens
inflammatori
respons
like
contribut
diseas
later
phase
infect
st
loui
enceph
dengu
exampl
flavivir
infect
precis
role
still
need
determin
tabl
list
clinic
trial
target
receptor
human
diseas
seen
major
ongo
clinic
trial
involv
antagon
receptor
target
therefor
exact
function
chemokin
context
human
diseas
still
remain
determin
minor
point
may
bind
multipl
receptor
target
receptor
may
activ
multipl
chemokin
figur
clearli
nonredund
function
chemokin
receptor
uncov
particular
molecul
target
human
antagonist
rant
rant
mkey
tabl
prevent
bind
gag
oligomer
molecul
compet
directli
function
mechan
action
distinct
receptor
antagon
may
provid
insight
biolog
human
diseas
howev
best
knowledg
modifi
molecul
taken
human
yet
recent
antibodi
target
novimmun
sa
tabl
pass
phase
clinic
studi
becom
avail
human
experiment
instrument
determin
exact
role
human
diseas
marqu
receiv
sponsorship
brazilian
fund
agenc
cnpq
mm
teixeira
rc
russo
receiv
fund
variou
brazilian
support
agenc
cnpq
fapemig
finep
grant
european
commun
r
guabiraba
receiv
sponsorship
wellcom
trust
uk
author
state
conflict
interest
